Steven B. Miller's most recent trade in BrightSpring Health Services Inc was a trade of 11,912 Common Stock done . Disclosure was reported to the exchange on May 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
BrightSpring Health Servic... | Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2025 | 11,912 | 22,620 | - | 0 | Common Stock | |
BrightSpring Health Servic... | Steven B. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 10,708 | 10,708 | - | 0 | Common Stock | |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 3,831 | 31,377 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.31 per share. | 26 Feb 2021 | 1,715 | 28,439 (0%) | 0% | 210.3 | 360,682 | Common Stock, $.01 Par Value |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 209.90 per share. | 26 Feb 2021 | 840 | 30,154 (0%) | 0% | 209.9 | 176,316 | Common Stock, $.01 Par Value |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.31 per share. | 26 Feb 2021 | 383 | 30,994 (0%) | 0% | 210.3 | 80,549 | Common Stock, $.01 Par Value |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 6,134 | 6,134 | - | - | Employee Stock Option (Right to Buy) | |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2021 | 1,287 | 27,546 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.53 per share. | 04 Feb 2021 | 622 | 26,259 (0%) | 0% | 210.5 | 130,950 | Common Stock, $.01 Par Value |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 210.00 per share. | 06 Jan 2021 | 8,972 | 26,104 (0%) | 0% | 210 | 1,884,120 | Common Stock, $.01 Par Value |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 8,972 | 777 | - | - | Employee Stock Option (Right to Buy) | |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.66 per share. | 06 Jan 2021 | 8,972 | 35,076 (0%) | 0% | 160.7 | 1,441,462 | Common Stock, $.01 Par Value |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 777 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Cigna Group (The) | Steven B. Miller | EVP, Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.66 per share. | 06 Jan 2021 | 777 | 26,881 (0%) | 0% | 160.7 | 124,835 | Common Stock, $.01 Par Value |